You are here

AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
The Savin Center
New Haven, Connecticut, 06511 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Clinical diagnosis of stable mild-to-moderate plaque-type psoriasis involving 2-35% of
total body surface area (BSA) excluding face, scalp, and genitals

- Willingness and ability to apply study medication as directed, comply with study
instructions, and commit to attending all study visits

- Women of childbearing potential must agree to use contraception for the entire study
period

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any dermatological conditions that could interfere with clinical evaluations

- Concurrent or recent use of certain topical or systemic medications without a
sufficient washout period

- Significant confounding conditions as assessed by study doctor

- Participated in any other trial of an investigational drug within 30 days or
participation in a research study concurrent with this study

- Use of lithium- or hydroxychloroquine-containing products (e.g., Plaquenil)

- Use of a beta-blocking medication (e.g., propranolol) if the dose has not been
stabilized for at least 3 months

- Pregnancy or lactation

NCT01300052
Pfizer
Completed
AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriasis, Psoriatic Arthritis
NCT00161655
All Genders
18+
Years
Multiple Sites
Psoriatic Arthritis, Psoriasis, Papulosquamous Skin Diseases
NCT00293722
All Genders
18+
Years
Toerwang-Samerberg,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now